Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

LI Ibanez, M De Filette, A Hultberg… - Journal of Infectious …, 2011 - academic.oup.com
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. We assessed the protective potential of …
被引用次数：127 相关文章
[PDF] archive.org

[PDF][PDF] Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

LI Ibanez, M De Filette, A Hultberg… - The Journal of …, 2011 - scholar.archive.org
The recombinant H5N1-HA–specific VHHs (H5-VHH) Nanobodies used in this study have
been described elsewhere (Anna Hultberg, Nigel J. Temperton, Valérie Rosseels, Mireille …

Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

LI Ibanez, M De Filette, A Hultberg, T Verrips… - The Journal of …, 2011 - gala.gre.ac.uk
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. Weassessed the protective potential …

Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

LI Ibañez, M De Filette, A Hultberg… - The Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. We assessed the protective potential of …

Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

L Ibanez, M De Filette, A Hultberg, T Verrips… - JOURNAL OF …, 2011 - biblio.ugent.be
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. We assessed the protective potential of …
[PDF] academia.edu

[PDF][PDF] Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

LI Ibanez, M De Filette, A Hultberg, T Verrips… - The Journal of …, 2011 - academia.edu
The recombinant H5N1-HA–specific VHHs (H5-VHH) Nanobodies used in this study have
been described elsewhere (Anna Hultberg, Nigel J. Temperton, Valérie Rosseels, Mireille …

Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection.

LI Ibañez, M De Filette, A Hultberg… - Journal of Infectious …, 2011 - search.ebscohost.com
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. We assessed the protective potential of …

[引用][C] Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

L ITATI IBANEZ, M DE FILETTE… - The Journal of …, 2011 - pascal-francis.inist.fr
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus
Infection CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

LI Ibañez, M De Filette, A Hultberg, T Verrips… - Journal of Infectious …, 2011 - kar.kent.ac.uk
Influenza A virus infections impose a recurrent and global disease burden. Current antivirals
against influenza are not always effective. Weassessed the protective potential …
[PDF] researchgate.net

[PDF][PDF] Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

LI Ibanez, M De Filette, A Hultberg… - The Journal of …, 2011 - researchgate.net
The recombinant H5N1-HA–specific VHHs (H5-VHH) Nanobodies used in this study have
been described elsewhere (Anna Hultberg, Nigel J. Temperton, Valérie Rosseels, Mireille …